Skip to main content
. Author manuscript; available in PMC: 2013 Apr 3.
Published in final edited form as: Lancet Oncol. 2009 Mar;10(3):258–266. doi: 10.1016/S1470-2045(08)70342-5

Table 1.

Patient Characteristics (N=153)

Variable Group N %
Age at CRT (year) Mean 4·9 SD 4·4
Median 2·9 range 0·9 to 22·9
Age at Diagnosis (year) Mean 4·4, SD 4. ·4
Median 2·4, range 0 to 22·7
Elapsed days of CRT Mean 44, SD 2·5
Median 44, range 37 to 56
Age < 3 years 78 51.0
≥ 3 years 75 49.0
Tumor Grade Differentiated 68 44·4
Anaplastic 85 55·6
Tumor Location Infratentorial 122 79·7
Supratentorial 31 20·3
Race White 126 82·4
Black 19 12·4
Hispanic 6 3·92
Asian 2 1·31
Gender Female 58 37·9
Male 95 62·1
Total dose 54 22 14·4
59·4 131 85·6
Surgery number 1 87 56·9
2 51 33·3
3 11 7·19
4 4 2·61
Surgery extent GTR 125 81·7
NTR 17 11·1
STR 11 7·19
Pre-CRT chemotherapy yes 35 22·9
no 118 77·1
Death No 130 85
Yes 23 15
Recurrence distant only 15 9·8
local and distant 7 4·58
local only 14 9·15
none 117 76·5

Legend: CRT, conformal radiation therapy; GTR, gross-total resection; NTR, near-total resection; STR, sub-total resection.